AB821
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AB821, covering 2026-02-25 to 2026-02-25. Get the full timeline:
Most recent: Clinical Trial Update: AB821 in Adult Participants With Locally Advanced or Metastatic Solid Tumors [Phase 1]